CATEGORY
Aspirin
Beroe LiVE.Ai™
AI-powered self-service platform for all your sourcing decision needs across 1,600+ categories llike Aspirin.
Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.
Aspirin Market Monitoring Dashboard
Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™
Aspirin Industry Benchmarks
Savings Achieved
(in %)
The average annual savings achieved in Aspirin category is 20.10%
Payment Terms
(in days)
The industry average payment terms in Aspirin category for the current quarter is 54.3 days
Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™
Category Strategy and Flexibility
Engagement Model
Supply Assurance
Sourcing Process
Supplier Type
Pricing Model
Contract Length
SLAs/KPIs
Lead Time
Supplier Diversity
Targeted Savings
Risk Mitigation
Financial Risk
Sanctions
AMEs
Geopolitical Risk
Cost Optimization
Price per Unit Competitiveness
Specification Leanness
Minimum Order Quality
Payment Terms
Inventory Control
The World’s first Digital Market Analyst
Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions
Aspirin Suppliers

Find the right-fit aspirin supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.


Aspirin Market Intelligence
global market outlook
- The global market size is around 28KT in 2020 and it is expected to grow with a CAGR of ~6%
- The key suppliers for Aspirin are Novacyl, Shandong Xinhua Pharmaceutical, JQC (Huayin) Pharmaceutical, The Andhra Sugars, Cabarria and Yamamoto Chemical Industry
- The global capacity is around 400,000 MT and the demand is around 28,000 MT, hence supply crunch is not expected for next few years
- China, Spain, France, and Thailand contribute to 93 percent of the global production
- The Innovator company of Aspirin and the current major producer of Aspirin is in Europe. Europe is mature, in terms of the supply market. There are two CEP holders and two DMF holders in Europe. The price of Aspirin from Europe is 20–25 percent higher than Asia
-
APAC has the highest number of suppliers of Aspirin with 50 percent of the supply market share.
The suppliers in India and China are of both medium and large scale. APAC suppliers have two active CEP and four active DMF suppliers of Aspirin

Use the Aspirin market, supplier and price information for category strategy creation and Quaterly Business Reviews (QRBs)
Aspirin market report transcript
Aspirin Global Market Outlook:
Global market size – 28 KT (2020)
Expected to grow at a CAGR of 6 percent
Market Trends:
Aspirin manufactures are increasing capacity, in response to
the increasing demand of the market.
Porter's Analysis on Aspirin
Supplier Power
- The market of Salicylic Acid used in the manufacture of Aspirin is fragmented with many players available in the market
- Some of the key market players also have salicylic acid in their product portfolio
- Salicylic Acid is majorly used in pharmaceutical manufacturing. The demand from other industries is minimal
- Hence, the suppliers of Aspirin raw materials has lower power
Barriers to New Entrants
- Consolidated Market: The Aspirin API market is consolidated with the top three players, holding close to 70 percent of the market share
- The top players have all the required regulatory certifications and an established consumer base
- Capital investment and competition are the major barriers for the new entrants in the market
Intensity of Rivalry
- Consolidated Market: As the marker is consolidated, each of the regulated suppliers have significant marker share. Hence, there is no problem of price competition
- Capacity Expansion: The established suppliers have been increasing their manufacturing capacities in response to the growing market demand
Threat of Substitutes
- Aspirin, being used for a wide range of indications, has lower risk of substitution, due to the low toxicity profile and established usage among the health care professionals
- However, the novel molecules, being introduced in the market for cardio vascular indication, etc., could effect the market size
Buyer Power
- The buyer has medium power, since the market is consolidated with lower number of regulated suppliers and their high market share